Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis T. Steinmetz, N. Eliakim-Raz, E. Goldberg, L. Leibovici, D. Yahav Clinical Microbiology and Infection Volume 21, Issue 7, Pages 665-673 (July 2015) DOI: 10.1016/j.cmi.2015.04.003 Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions
Fig. 1 Study flow diagram. Clinical Microbiology and Infection 2015 21, 665-673DOI: (10.1016/j.cmi.2015.04.003) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions
Fig. 2 All-cause mortality. An odds ratio of >1 favours high vancomycin level. Clinical Microbiology and Infection 2015 21, 665-673DOI: (10.1016/j.cmi.2015.04.003) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions
Fig. 3 Treatment failure. An odds ratio of >1 favours high vancomycin level. Clinical Microbiology and Infection 2015 21, 665-673DOI: (10.1016/j.cmi.2015.04.003) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions
Fig. 4 Microbiologic failure. An odds ratio of >1 favours high vancomycin level. Clinical Microbiology and Infection 2015 21, 665-673DOI: (10.1016/j.cmi.2015.04.003) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions